Clinical Trials Directory

Trials / Unknown

UnknownNCT05528068

Effect of Lifestyle Intervention Among Patients With Hypertension or High-normal Blood Pressure

Effect of Lifestyle Intervention Based on Continuous Physiological Monitoring Among Patients With Hypertension or High-normal Blood Pressure

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
424 (estimated)
Sponsor
China National Center for Cardiovascular Diseases · Other Government
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Hypertension is a major risk factor for cardiovascular disease and cardiovascular events. Healthy lifestyle factors are widely recommended for hypertension prevention and control, and cardiorespiratory fitness is a strong and independent predictor of the progression of hypertension. Increased cardiorespiratory fitness through lifestyle modifications is associated with lower mortality in hypertensive or high-normal blood pressure individuals. The aim of the study is to evaluate the effects of supervised lifestyle intervention that include diet and exercise and base on intelligent application and continuous physiological monitoring on improvement of cardiopulmonary fitness, blood pressure and other health outcomes among participants with hypertension or high-normal blood pressure.

Conditions

Interventions

TypeNameDescription
BEHAVIORALsupervised lifestyle interventionParticipants will receive personalized dietary and exercise prescription according to the assessment of nutritional status, physical fitness and physiological-biochemical indexes. The participants will use the digital application for the first 3 months with supervised lifestyle intervention. Wearable devices, such as ambulatory blood pressure monitoring, dynamic electrocardio scanner and smart watch, will be worn to provide continuous physiological monitoring for safety. And then, participants will use the application by self-management for the next 6 months. All participants are given questionnaires, nutritional, physical fitness and physiological-biochemical assessment at baseline, 3 months, 6 months and 9 months.
BEHAVIORALhealthy lifestyle educationParticipants will receive standard care and healthy lifestyle education for hypertension prevention and control. Wearable devices, such as ambulatory blood pressure monitoring, dynamic electrocardio scanner and smart watch, will be worn to provide continuous physiological monitoring for safety. Participants will use the application by self-management for 9 months. All participants are given questionnaires, nutritional, physical fitness and physiological-biochemical assessment at baseline, 3 months, 6 months and 9 months.

Timeline

Start date
2022-07-27
Primary completion
2023-04-27
Completion
2023-10-27
First posted
2022-09-06
Last updated
2022-09-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05528068. Inclusion in this directory is not an endorsement.